Synergy Pharmaceuticals Reports 2012 Fourth Quarter and Full-Year Financial Results

Synergy Pharmaceuticals Reports 2012 Fourth Quarter and Full-Year Financial Results

[at noodls] – NEW YORK, March 18, 2013 — Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its financial results and business update … more

View todays social media effects on SGYPU

View the latest stocks trending across Twitter. Click to view dashboard

See who Synergy is hiring next, click here to view

Share this post